ARTICLE | Company News
Peplin Biotech Ltd., Progen Industries deal
March 17, 2003 8:00 AM UTC
PGL will manufacture PEP’s PEP005 topical compound for Phase I testing to treat non-melanoma skin cancer. Allergan (AGN, Irvine, Calif.) has exclusive rights to develop and market PEP005 in North and...